Do generics producers have what it takes to tackle complex and specialty drugs?
Pharmaceutical Technology
JULY 25, 2022
Margins in the generics market are overall being driven down, Harvard Medical School Health Economics professor Richard Frank, PhD, tells Pharmaceutical Technology. But if it differs in a range of characteristics, including administration or dosage, it should be submitted through the 505 (b) (2) pathway.
Let's personalize your content